1. Home
  2. UCAR vs ADIL Comparison

UCAR vs ADIL Comparison

Compare UCAR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$0.51

Market Cap

7.0M

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$1.96

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCAR
ADIL
Founded
2013
2010
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
6.4M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
UCAR
ADIL
Price
$0.51
$1.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$37.50
AVG Volume (30 Days)
73.4K
95.4K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.13
52 Week High
$4.98
$3.67

Technical Indicators

Market Signals
Indicator
UCAR
ADIL
Relative Strength Index (RSI) 21.10 51.48
Support Level N/A $0.28
Resistance Level $2.17 $3.67
Average True Range (ATR) 0.11 0.24
MACD -0.10 -0.12
Stochastic Oscillator 0.67 36.61

Price Performance

Historical Comparison
UCAR
ADIL

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Share on Social Networks: